North America

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy ...

QinFlow Launches Advanced Fluid and Blood Warming Solution to Meet Critical Needs in ORs and ICUs

Founded in 2009, QinFlow is a market leader in fluid thermoregulation solutions. ...

Voxela Officially Launches Next-Generation AI Eldercare Solution “Voxela VCare Pro”

Enhancing eldercare with real-time monitoring, automated reports, and predictive analytics ...

BiVACOR Total Artificial Heart Accepted into FDA’s TAP Program

This milestone further solidifies BiVACOR’s collaboration with the FDA following the TAH’s earlier recognition this year as a Breakthrough Device...

BD Becomes First MedTech Company to Earn Diamond-Level Resiliency Badge Across All HIRC Supply Chain Domains

BD’s Urology and Critical Care and Surgery units achieve top-tier recognition from the Healthcare Industry Resilience Collaborative, affirming its leadership in supply chain transparency, risk mitigation, and operational excellence...

Synchron Enables First Thought-Controlled iPad Experience

Synchron Debuts First Thought-Controlled iPad Experience Using Apple’s New BCI Human Interface Device Protocol ...

BMI OrganBank Secures FDA Breakthrough Device Designation for Innovative Kidney Transplant Technology

BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys...

BD Invests $35M to Expand U.S. Production of PosiFlush™ Prefilled Syringes

The expansion at its Nebraska facility will boost syringe output by hundreds of millions annually, enhancing supply resilience and supporting safe, high-quality patient care across U.S. hospitals....

Concept Medical Launches Major U.S. Trial for Sirolimus-Coated Balloon in Small Vessels

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe...

The FDA Is Phasing Out Animal Testing. Our Replacements Must Catch Up Fast.

In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead. ...